Find A Doctor

Start A New Search

Vikas Bhambhani, MD

Physician

(612) 813-7240

Specialties: Genetics/Genomics | Genetics/Genomics, Medical | Genetics/Genomics, Medical Biochemical

Fluent Languages: Hindi

Professional History

Board Certification

  • Clinical Genetics - American Board of Medical Genetics and Genomics
  • Medical Biochemical Genetics - American Board of Medical Genetics and Genomics
  • Pediatrics - American Board of Pediatrics

Medical Education

  • MBBS - Maulana Azad Medical College
    New Delhi
    1999

Residency/Fellowship

  • Residency - New York Medical College
    Valhalla, NY
    2010
  • Fellowship - National Institutes of Health
    Bethesda, MD
    2013
  • Fellowship - National Institutes of Health
    Bethesda, MD
    2012

Contact Information

Primary Location:

Childrens Minnesota Genetics
2545 Chicago Ave S STE 700
Minneapolis, MN 55404
(612) 813-7240

Secondary Location(s):

Childrens Minnesota Down Syndrome Clinic
2525 Chicago Ave S CSC 390
Minneapolis, MN 55404
(612)813-6777

Childrens Minnesota Down Syndrome Clinic
345 N Smith Ave STE 70-302
St Paul, MN 55102
(612)813-6777

Childrens Minnesota Genetics
345 N Smith Ave STE 61-245
St Paul, MN 55102
(612) 813-7240

Personal Biography

Board Certification •Clinical Genetics - American Board of Medical Genetics and Genomics •Medical Biochemical Genetics - American Board of Medical Genetics and Genomics •Pediatrics - American Board of Pediatrics Medical Education •MBBS - Maulana Azad Medical College, New Delhi, India Residency/Fellowship •Residency - New York Medical College, Valhalla, NY •Fellowship - National Institutes of Health, Bethesda, MD •Fellowship - National Institutes of Health, Bethesda, MD Research :Current Projects 2020- Physician Investigator, “Single Patient Expanded Access Use of EPI-743 (Vatiquinone)”PTC Therapeutics, Inc. 2020- Site Principal Investigator, “Cerliponase alfa Observational Study”BioMarin Pharmaceutical, Inc. 2020- Site Principal Investigator, “LAL Deficiency Registry”BioMarin Pharmaceutical, Inc. 2019- Site Principal Investigator, “MPS VI Clinical Surveillance Program (CSP)”BioMarin Pharmaceutical Inc. 2018- Site Principal Investigator, “Rare Disease Registries: Fabry, Gaucher, MPS I and Pompe”Sanofi Genzyme 2015- Site Principal Investigator, “Hunter Outcome Survey: A Global, Multi-Center, Long-Term, Observational Registry of Patients with Hunter Syndrome (MPS II)”Shire Human Genetic Therapies, Inc. 2015- Site Principal Investigator, “Gaucher Disease Outcome Survey (GOS)” Shire Human Genetic Therapies, Inc. 2014- Site Principal Investigator, “Morquio A Registry Study (MARS)”BioMarin Pharmaceutical Inc. Special Interests:Mitochondrial disorder, Leukodystrophy, Refractory epilepsy and Neurotransmitter deficiency.